IMAX is trading about 10% up at $43.22 after reporting a sizable Q2 2026 earnings beat and reaffirming record full-year guidance.
- Management highlighted record margins and strong performance from Christopher Nolanβs The Odyssey, while reaffirming guidance for a record full-year global box office.
- Robust system installs and a bullish 2026 outlook are helping the stock outperform a weak broader market.